JPMorgan Wealth Management Releases 2025 Summer Reading List Featuring AI and Leadership Themes Shrinking Oil Inventories Raise Concerns Over Energy Supply Stability Rocket Labs Strategic Shift Raises Investor Uncertainty Morrisons to Close 100 Stores Amid Cost Pressures from Government Policies Wall Street Rises Dow Hits Record High Amid Optimism Over Middle East Developments Gold Price Outlook Analysts Eye 6000 By 2026 Amid Economic Uncertainty INFQ Q1 2026 Earnings Loss Per Share Widens Stock Surges on No Estimate Comparison BKYI Q1 2026 Earnings Significant EPS Beat Amidst Ongoing Operational Challenges ITW Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher Endeavour Silver EXK Q1 2026 Earnings Silver Producer Beats EPS Estimates by Nearly 60 Shares Dip Slightly JD Q1 2026 Earnings EPS Misses Estimates Shares Decline on Weak Profitability UTHR Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Sylvamo Corporation SLVM Rallies Toward Resistance Amid Volume Shift Waldencast Warrants WALDW Edge Higher at 004 Amid Tight Trading Range Definium Therapeutics DFTX Slips 066 as Shares Test Key Support Zone Iovance Biotherapeutics Surges Over 6 as Biotech Sector Momentum Builds Highwoods Properties HIW Edges Higher as Real Estate Sector Shows Signs of Stabilization Pediatrix Medical Group MD Q1 2026 Earnings EPS Beats Estimates by Nearly 13 as Stock Declines AHRT Q1 2026 Earnings EPS Misses Estimates by 164 Stock Rises Slightly Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment Versamet Royalties Corporation VMET Q1 2026 Earnings Massive EPS Beat Boosts Investor Sentiment Iveda Solutions Q2 2024 Earnings Loss Narrows More Than Expected Revenue Remains Undisclosed SILO Q4 2023 Earnings Biotech Misses EPS Estimates as PreRevenue Phase Continues Retailers Deploy Dual Strategies of Price Cuts and Premiumization to Navigate KShaped Economy EuroDry Ltd EDRY Q1 2026 Earnings Dry Bulk Shipping Headwinds Sink Earnings Stock Edges Higher Allogene Therapeutics ALLO Surges 6 Can the Biotech Reclaim Key Resistance